These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8399615)

  • 1. Quinolones: pharmacokinetics and pharmacodynamics.
    Nikolaidis PP
    Perit Dial Int; 1993; 13 Suppl 2():S377-9. PubMed ID: 8399615
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of quinolones: newer aspects.
    Wolfson JS; Hooper DC
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):267-74. PubMed ID: 1864287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis.
    Passadakis P; Oreopoulos D
    Adv Perit Dial; 2001; 17():180-90. PubMed ID: 11510271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer quinolones in the treatment of continuous ambulatory peritoneal dialysis (CAPD) related infections.
    Nikolaidis P
    Perit Dial Int; 1990; 10(2):127-33. PubMed ID: 2085597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacodynamic properties of quinolones.
    Wiedemann B; Rustige-Wiedemann C; Kratz B
    Drugs; 1995; 49 Suppl 2():269-71. PubMed ID: 8549328
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis].
    Daniel JP; Moulin B; Christmann D
    Ann Pharm Fr; 2004 May; 62(3):177-85. PubMed ID: 15243351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of pharmacokinetics and pharmacodynamics of antimicrobial agents.
    Estes L
    Mayo Clin Proc; 1998 Nov; 73(11):1114-22. PubMed ID: 9818049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of fleroxacin in horses.
    Rebuelto M; Otero P; Albarellos G; Ambros L; Kreil V; Waxman S; Montoya L; Hallu R
    J Vet Pharmacol Ther; 2000 Apr; 23(2):103-5. PubMed ID: 10849255
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
    Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and pharmacokinetics of enoxacin.
    Nakamura S; Kurobe N; Sekine Y
    J Chemother; 1989 Jul; 1(4 Suppl):543-4. PubMed ID: 16312524
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens.
    Bugyei K; Black WD; McEwen S
    Can J Vet Res; 1999 Jul; 63(3):193-200. PubMed ID: 10480461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of single-dose oral enrofloxacin in the horse.
    Langston VC; Sedrish S; Boothe DM
    J Vet Pharmacol Ther; 1996 Aug; 19(4):316-9. PubMed ID: 8866463
    [No Abstract]   [Full Text] [Related]  

  • 14. Enrofloxacin in salmonids.
    Bowser PR; Babish JG
    Vet Hum Toxicol; 1991; 33 Suppl 1():46-8. PubMed ID: 1926748
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intracellular pharmacokinetics and pharmacodynamics of antibiotics].
    Tulkens PM
    Rev Pneumol Clin; 1996; 52 Suppl 2():S51-5. PubMed ID: 9033918
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacodynamics of quinolones.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():197-9. PubMed ID: 8549302
    [No Abstract]   [Full Text] [Related]  

  • 17. Developments in quinolones. Bacteriology, pharmacokinetics and initial clinical experience of several investigational quinolone derivatives.
    Janknegt R; Hekster YA
    Pharm Weekbl Sci; 1989 Apr; 11(2):33-43. PubMed ID: 2657644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and drug dosage adjustment to renal impairment.
    Keller F; Giehl M; Frankewitsch T; Zellner D
    Nephrol Dial Transplant; 1995; 10(9):1516-20. PubMed ID: 8559456
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
    Wise R; Johnson J; O'Sullivan N; Andrews JM; Imbimbo BP
    J Antimicrob Chemother; 1991 Dec; 28(6):905-9. PubMed ID: 1667783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of fosfomycin and quinolones in peritoneal dialysis solution.
    Quentin C; Bouchet JJ; Gaillard I; Bebear C
    J Antimicrob Chemother; 1990 May; 25(5):878-80. PubMed ID: 2373672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.